Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

Advances in Experimental Pharmacology and Drug Discovery have encountered a crucial but often overlooked challenge: gender inequality. Despite the pivotal ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and its affiliated Institute for Research in Immunology and Cancer are working ...

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...